Nalaganje...

ASCO 2018: highlights in HER2-positive metastatic breast cancer

At the 2018 ASCO Annual Meeting, data from several interesting studies in HER2-positive metastatic breast cancer were presented. While not immediately practice changing, these trials indicate the future directions of drug development in this field. Early phase studies with novel antibody-drug conjug...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Memo
Main Authors: Bartsch, Rupert, Bergen, Elisabeth
Format: Artigo
Jezik:Inglês
Izdano: Springer Vienna 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280772/
https://ncbi.nlm.nih.gov/pubmed/30595754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-018-0441-x
Oznake: Označite
Brez oznak, prvi označite!